StonvexLoading…
StonvexCore line items from ZBRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.40B | $4.98B | $4.58B | $5.78B |
Operating Income | $700.00M | $742.00M | $481.00M | $529.00M |
Net Income | $419.00M | $528.00M | $296.00M | $463.00M |
EPS (Diluted) | $8.18 | $10.18 | $5.72 | $8.80 |
Total Assets | $8.50B | $7.97B | $7.31B | $7.53B |
Total Liabilities | $4.91B | $4.38B | $4.27B | $4.80B |
Cash & Equivalents | $125.00M | $901.00M | $137.00M | $105.00M |
Free Cash Flow OCF − CapEx | $831.00M | $954.00M | $-91.00M | $413.00M |
Shares Outstanding | 51.21M | 51.88M | 51.71M | 52.56M |